Biosynex
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
ALBIO | PA
Overview
Corporate Details
- ISIN(s):
- FR0011005933
- LEI:
- 969500H4BGE1HBLGP566
- Country:
- France
- Address:
- 22 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN
- Website:
- https://www.biosynex.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Founded in 2005, Biosynex is a key European manufacturer specializing in the in-vitro diagnostics market. The company designs, manufactures, and distributes Rapid Diagnostic Tests (RDTs) for both professional and public use. Its product portfolio includes Point-of-Care (POC) solutions, molecular biology assays, and self-tests available in pharmacies, which are utilized for screening, diagnosis, and prevention. Biosynex's tests are engineered for speed and simplicity, aiming to facilitate better medical management and patient care. The company distributes its products internationally to over 90 countries, serving healthcare professionals such as biologists and doctors, as well as the general consumer market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-22 18:00 |
Earnings Release
BIOSYNEX SA: RESULTATS SEMESTRIELS 2025
|
French | 111.9 KB | ||
| 2025-09-29 18:00 |
Legal Proceedings Report
BIOSYNEX annonce louverture dune procedure de sauvegarde pour restructurer son …
|
French | 20.4 KB | ||
| 2025-09-25 18:00 |
Legal Proceedings Report
BIOSYNEX SA: DEPOT DUNE DEMANDE DE PROCEDURE DE SAUVEGARDE POUR BIOSYNEX ET DUN…
|
French | 28.7 KB | ||
| 2025-07-29 18:45 |
Regulatory News Service
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT BREAKTHROUGH DE…
|
French | 28.7 KB | ||
| 2025-07-17 18:00 |
Earnings Release
BIOSYNEX SA: CHIFFRE DAFFAIRES DU PREMIER SEMESTRE 2025 : 50,8 M (-6%)
|
French | 50.6 KB | ||
| 2025-06-17 18:00 |
Regulatory News Service
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT “BREAKTHROUGH D…
|
French | 329.2 KB | ||
| 2025-06-17 18:00 |
Regulatory News Service
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT BREAKTHROUGH DE…
|
French | 29.2 KB | ||
| 2025-04-23 18:00 |
Earnings Release
BIOSYNEX SA: RESULTATS ANNUELS 2024 - ACCELERATION DE LA REORGANISATION DU GROU…
|
French | 389.4 KB | ||
| 2025-04-23 18:00 |
Earnings Release
BIOSYNEX SA: RESULTATS ANNUELS 2024 - ACCELERATION DE LA REORGANISATION DU GROU…
|
French | 108.9 KB | ||
| 2025-03-06 18:03 |
Major Shareholding Notification
Franchissement de seuil
|
French | 221.4 KB | ||
| 2025-03-05 18:00 |
Declaration of Voting Results & Voting Rights Announcements
BIOSYNEX SA: DECLARATION DU NOMBRE DACTIONS ET DES DROITS DE VOTE AU 28 FEVRIER…
|
French | 23.2 KB | ||
| 2025-03-04 18:00 |
Declaration of Voting Results & Voting Rights Announcements
BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 28 FEVRIE…
|
French | 127.2 KB | ||
| 2025-03-04 18:00 |
Declaration of Voting Results & Voting Rights Announcements
BIOSYNEX SA: DECLARATION DU NOMBRE DACTIONS ET DES DROITS DE VOTE AU 28 FEVRIER…
|
French | 23.2 KB | ||
| 2025-03-04 17:00 |
Declaration of Voting Results & Voting Rights Announcements
BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 28 FEVRIE…
|
French | 127.2 KB | ||
| 2025-02-13 08:00 |
Share Issue/Capital Change
BIOSYNEX SA: BIOSYNEX ANNONCE LE SUCCES DE SON AUGMENTATION DE CAPITAL AVEC MAI…
|
French | 120.7 KB |
Automate Your Workflow. Get a real-time feed of all Biosynex filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biosynex
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biosynex via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
